Susquehanna International Group’s Arcadia Biosciences RKDA Stock Holding History

Susquehanna International Group’s Portfolio RKDA Stock Details RKDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$17.4K	Buy	+12,614	New	+$24.7K	﹤0.01%	12878
2023 Q1	–	Sell	-7,060	Closed	-$76.5K	–	13344
2022 Q4	$76.5K	Buy	7,060 +3,241	+85%	+$46.2K	﹤0.01%	11165
2022 Q3	$81K	Buy	3,819 +735	+24%	+$25.1K	﹤0.01%	11873
2022 Q2	$123K	Sell	3,084 -2,656	-46%	-$122K	﹤0.01%	11257
2022 Q1	$321K	Buy	5,740 +1,848	+47%	+$88.1K	﹤0.01%	10108
2021 Q4	$162K	Sell	3,892 -1,451	-27%	-$94.6K	﹤0.01%	11708
2021 Q3	$442K	Buy	+5,343	New	+$501K	﹤0.01%	9702
2021 Q2	–	Sell	-3,391	Closed	-$370K	–	13149
2021 Q1	$373K	Sell	3,391 -1,173	-26%	-$144K	﹤0.01%	10139
2020 Q4	$461K	Buy	4,564 +4,128	+947%	+$504K	﹤0.01%	8469
2020 Q3	$49K	Buy	+436	New	+$58.9K	﹤0.01%	10202
2018 Q4	–	Sell	-343	Closed	-$67K	–	9817
2018 Q3	$67K	Buy	+343	New	+$86.2K	﹤0.01%	8753

Other funds holding RKDA

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Susquehanna International Group's RKDA Position: Q1 2026 in Review

Susquehanna International Group opened a new position in Arcadia Biosciences (RKDA) in Q1 2026: 12,614 shares worth $17.4K. The stake represents ﹤0.01% of the portfolio and ranks #12878 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in RKDA as recently as Q4 2022.

Susquehanna International Group first reported a position in RKDA in Q3 2018 and has held it in 11 quarters since. The position peaked at $461K in Q4 2020. 16 funds tracked by Wall St. Rank hold RKDA as of Q1 2026.

Susquehanna International Group held 12,614 shares of Arcadia Biosciences worth $17.4K as of Q1 2026.
Arcadia Biosciences was a new Susquehanna International Group position in Q1 2026.
Arcadia Biosciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12878 holding.
Susquehanna International Group first reported a position in Arcadia Biosciences in Q3 2018 and has held it in 11 quarters since.
Susquehanna International Group's Arcadia Biosciences position peaked at $461K in Q4 2020.
16 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.